Elsevier / MC Strategies Introduces Additional Resources to its ICD-10 Roadmap, Helping Healthcare Organizations Prepare for October 2013

“Two Years and Counting” white paper helps users plan their transition schedule and identify critical milestones and educational needs

Atlanta, GA, August 9, 2011 – Elsevier / MC Strategies, a pioneer in providing eLearning solutions to more than 1,300 healthcare organizations, today announced the addition of a white paper, “Two Years and Counting”, as well as updates to its eBook,A Guide to Education and Training for ICD-10 Implementation, to its ICD-10 Roadmap.

Elsevier’s ICD-10 Roadmap is a comprehensive, phased transition plan that serves as a guide for successful planning and implementation. The roadmap is divided into four phases of the transition – evaluation, planning, action and management – and offers recommendations for planning as well as an educational program that provides the right training at the right time. As noted on the roadmap, organizations should now be performing gap analyses and improving the foundational knowledge of their staff. Elsevier’s ICD-10 Readiness Assessment tool, and Mosby’s Anatomy & Physiology, Pathophysiology and Medical Terminology Curricula will help ensure that organizations are ready for the next phase.

The newest white paper from Elsevier, “Two Years and Counting,” details where healthcare organizations should be in their transition process, and provides an in-depth look at the four phases of transition, including the steps that need to be taken in each phase to ensure a smooth transition. To further emphasize the need to act, Elsevier has added a Countdown to ICD-10 clock to their icd-10online.com web site.

“As the 2013 implementation date for the ICD-10 draws closer, the transition from ICD-9 is becoming a primary concern for many healthcare organizations,” said Deborah Neville, RHIA, CCS-P, PCS, Director of Revenue Cycle, Coding and Compliance, Elsevier/ MC Strategies. “There are numerous benefits to the early adoption of the ICD-10, including improvements in patient outcomes and quality measures reporting, revenue cycle analytics and associated reimbursement, improved data for research, and consistent coding with systems worldwide – all of which can be accomplished with the proper training and support.”

In addition to “Two Years and Counting”, Elsevier’s updated eBook provides educational recommendations with professional requirements and timelines in mind. As part of Elsevier’s commitment to ensuring a smooth transition to ICD-10, additional resources such as ICD-10 webinar recordings and a collection of ICD-10 white papers are available on www.ICD-10online.com, along with the eBook.

To stay current with the ICD-10 transition, please find Elsevier ICD-10 on Facebook at http://www.facebook.com/ICD10Online and on Twitter at @ICD10Online. For more information about Elsevier ICD-10 eLearning Solutions, including purchasing information, please visit www.ICD-10online.com or call +1 866 429 3067.
 

# # #


About Elsevier Clinical Decision Support
Elsevier Clinical Decision Support (www.clinicaldecisionsupport.com), a division of Elsevier, the global leader in medical and health information, provides world class information and point-of-care technology solutions that optimize decisions and actions to improve the overall quality, safety and cost-effectiveness of care. The business delivers on this promise through actionable clinical content, care planning and documentation, drug reference and decision support, learning and performance management, and data mining and outcomes analytics solutions for provider, pharmacy and payer organizations.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Tom Relle
Vice President of Global Relations, Elsevier
+ 1 212 462 1912
t.reller@elsevier.com